Veterinary Medicines

CANVAC DHPPiL+R

Authorised
  • Canine adenovirus 2, strain Toronto, Live
  • Canine parvovirus, strain T-86, Live
  • Canine distemper virus, strain Onderstepoort, Live
  • Canine parainfluenza virus, Live
  • Leptospira kirschneri, Serogroup Grippotyphosa, Inactivated
  • Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Icterohaemorrhagiae, strain 11403, Inactivated
  • Leptospira interrogans, serogroup Sejroe, serovar Wolffi, Inactivated
  • Rabies virus, strain PV Op VB X/96, Inactivated
Download as PDF

Product identification

Medicine name:
CANVAC DHPPiL+R
Active substance:
  • Canine adenovirus 2, strain Toronto, Live
  • Canine parvovirus, strain T-86, Live
  • Canine distemper virus, strain Onderstepoort, Live
  • Canine parainfluenza virus, Live
  • Leptospira kirschneri, Serogroup Grippotyphosa, Inactivated
  • Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Icterohaemorrhagiae, strain 11403, Inactivated
  • Leptospira interrogans, serogroup Sejroe, serovar Wolffi, Inactivated
  • Rabies virus, strain PV Op VB X/96, Inactivated
Target species:
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Canine adenovirus 2, strain Toronto, Live
    3.50
    log10 cell culture infective dose 50
    /
    1.00
    millilitre(s)
  • Canine parvovirus, strain T-86, Live
    2.10
    log10 cell culture infective dose 50
    /
    1.00
    millilitre(s)
  • Canine distemper virus, strain Onderstepoort, Live
    2.70
    log 10 50% embryo lethal dose
    /
    1.00
    millilitre(s)
  • Canine parainfluenza virus, Live
    3.00
    log10 cell culture infective dose 50
    /
    1.00
    millilitre(s)
  • Leptospira kirschneri, Serogroup Grippotyphosa, Inactivated
    32.00
    antibody unit(s)
    /
    1.00
    millilitre(s)
  • Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Icterohaemorrhagiae, strain 11403, Inactivated
    32.00
    antibody unit(s)
    /
    1.00
    millilitre(s)
  • Leptospira interrogans, serogroup Sejroe, serovar Wolffi, Inactivated
    32.00
    antibody unit(s)
    /
    1.00
    millilitre(s)
  • Rabies virus, strain PV Op VB X/96, Inactivated
    2.00
    international unit(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Lyophilisate and solvent for suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AJ06
Legal status of supply:
This information is not available for this product.
Authorisation status:
  • Valid
Authorised in:
  • Romania
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Complete application (stand-alone) - Directive No 2001/82/EC
Marketing authorisation holder:
  • Dyntec spol. s r.o.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Dyntec spol. s r.o.
Responsible authority:
  • Institute For Control Of Biological Products And Veterinary Medicines
Authorisation number:
  • 120304
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Romanian (PDF)
Published on: 18/05/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."